Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06596265 · ClinicalTrials.gov registry record

Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study

A clinical trial of Hypertension and Anxiety, sponsored by Duke University.

Recruiting
Registry status
1,000
Enrollment target
1
Study location

NCT06596265: Recruiting study of Hypertension and Anxiety, sponsored by Duke University.

NCT06596265 is a study of Hypertension and Anxiety that is actively recruiting participants, run by Duke University. The registered enrollment target is 1,000 participants, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06596265, a study of Hypertension and Anxiety, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
1,000 participants
Enrollment target
1
Study location

Study Summary

The Fit2Lead prospective cohort study examines the effects of a park-based youth mental health and resilience afterschool program on youth participant mental health, resilience, physical fitness, and violence prevention outcomes. Duke will perform a secondary analysis of the data collected as part of the Fit2Lead prospective cohort study run by Miami-Dade County Parks and Recreation.

Conditions Studied

Hypertension Anxiety Overweight or Obesity Prehypertension Wellness, Psychological Low Physical Fitness

Interventions

  • BEHAVIORAL Fit2Lead Group 1-2

Study Locations (1)

Florida

  • Miami-Dade County Parks, Recreation and Open Spaces Department - Miami

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2016-02-17
Est. Completion 2028-06-17
Duke University

1,725 total trials

What NCT06596265 shows while recruiting

NCT06596265 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (71% lower).

The record links to 6 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Fit2Lead Group 1-2 is the first listed.

NCT06596265 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06596265 about?

NCT06596265 is a clinical study titled "Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study". The Fit2Lead prospective cohort study examines the effects of a park-based youth mental health and resilience afterschool program on youth participant mental health, resilience, physical fitness, and violence prevention outcomes. Duke will perform a secondary analysis of the data collected as part o...

What is the current status of trial NCT06596265?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2016-02-17. Estimated completion is 2028-06-17.

What conditions does trial NCT06596265 study?

This clinical trial studies the following conditions: Hypertension, Anxiety, Overweight or Obesity, Prehypertension, Wellness, Psychological.

What interventions are being tested in trial NCT06596265?

The interventions under investigation include: Fit2Lead Group 1-2 (BEHAVIORAL).

Who is sponsoring clinical trial NCT06596265?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06596265 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06596265's enrollment target sits among peer trials

1,000 65th of 470 higher than 396 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06596265

Source: ClinicalTrials.gov NCT06596265, the US trial registry maintained by the National Library of Medicine. NCT06596265 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.